NCT05253131 2026-02-11Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for SarcomasUniversity of Alabama at BirminghamPhase 2 Not yet recruiting41 enrolled
NCT01206140 2015-10-05Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By SurgeryNational Cancer Institute (NCI)Phase 2 Completed70 enrolled 8 charts